Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Proteome Sciences Form Biomarker Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will collaborate with Proteome Sciences to develop quantitative proteomic workflows for biomarker discovery and validation.

The alliance will combine Proteome Sciences' isobaric mass tagging reagents with Thermo Fisher's mass spectrometry systems. Thermo Fisher said that Proteome Sciences has installed LTQ Orbitrap Velos and TSQ Vantage mass spec systems at its research labs in Frankfurt, Germany, to extend its biomarker discovery and validation workflows.

"When using the TSQ Vantage high-sensitivity triple quadrupole mass spectrometer in combination with our proprietary TMT tandem mass tag technology for assay development, we can offer the most integrated biomarker discovery, qualification, and assay validation workflows in the industry," Proteome Sciences COO Ian Pike said in a statement. "We have already successfully used TMT technology to develop mass spec assays for blood biomarkers in Alzheimer's disease and are extending our coverage for other proprietary biomarkers in cancer and brain damage."

Thermo Fisher noted that over the past three years Proteome Sciences has been working with researchers at its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center to adapt workflows for isotope dilution mass spectrometry assays based on the technique of selected reaction monitoring.

Proteome Sciences intends to expand its relationship with BRIMS to develop biomarker assays in Alzheimer's disease and cancer for clinical research applications.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.